openPR Logo
Press release

Pharmacogenomics - Top Companies Regional and Data Analysis

01-21-2025 03:05 PM CET | Health & Medicine

Press release from: The Insight Partners

Pharmacogenomics Market

Pharmacogenomics Market

Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.

Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129

Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacogenomics - Top Companies Regional and Data Analysis here

News-ID: 3825669 • Views:

More Releases from The Insight Partners

Roll-Your-Own Cigarette (MYO) Market Expected to Reach US$ 14.69 Billion by 2034, Growing at 4.92% CAGR
Roll-Your-Own Cigarette (MYO) Market Expected to Reach US$ 14.69 Billion by 2034 …
The global Roll-your-own Cigarette (MYO) Market is witnessing steady growth as consumers increasingly seek cost effective and customizable smoking alternatives. The Roll-your-own Cigarette (MYO) Market size is expected to reach US$ 14.69 Billion by 2034 from US$ 10. Billion in 2025. The market is estimated to record a CAGR of 4.92% from 2026 to 2034. Request Sample Pages of this Research Study @ https://www.theinsightpartners.com/sample/TIPRE00028338/?utm_source=OpenPR&utm_medium=10752 MYO cigarettes, which allow users to manually roll
Eyeshadow Palettes Market Expected to Reach US$ 6.01 Billion by 2034, Growing at 9.76% CAGR
Eyeshadow Palettes Market Expected to Reach US$ 6.01 Billion by 2034, Growing at …
The eyeshadow palettes market is witnessing substantial growth as consumers increasingly embrace beauty and personal care products that offer versatility, creativity, and long lasting performance. According to The Insight Partners, the Eyeshadow Palettes market was valued at US$ 2.60 billion in 2025 and is projected to reach US$ 6.01 billion by 2034, registering a CAGR of 9.76% during the forecast period from 2026 to 2034. Request Sample Pages of this Research
Global Aerospace High-Performance Alloys Market to Reach US$ 19.4 Billion by 2034 Driven by Next-Generation Aircraft Development
Global Aerospace High-Performance Alloys Market to Reach US$ 19.4 Billion by 203 …
The global aerospace high-performance alloys market is experiencing significant growth as aircraft manufacturers increasingly focus on lightweight, durable, and high-strength materials to improve fuel efficiency, operational performance, and sustainability. Aerospace high-performance alloys are widely used in aircraft structures, engines, landing gear systems, and other critical components due to their superior mechanical strength, corrosion resistance, and ability to withstand extreme temperatures. According to The Insight Partners, the Aerospace High-Performance Alloys Market is
United States Endoscope Tip Protectors Market Size, Share and Growth Forecast 2026-2034
United States Endoscope Tip Protectors Market Size, Share and Growth Forecast 20 …
The United States Endoscope Tip Protectors Market represents the largest share within North America, driven by a well-established healthcare system, increasing procedural volumes, and strong emphasis on infection control practices. Healthcare providers are adopting advanced endoscope protection products to improve equipment longevity and ensure compliance with reprocessing and storage protocols. Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00013457?utm_source=OpenPR&utm_medium=10812 The Global Endoscope Tip Protectors Market Demand is witnessing steady growth due to increasing awareness of patient

All 5 Releases


More Releases for Pharmacogenomics

Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market. Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period. Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776 The pharmacogenomics market is segmented on the basis of
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028. The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy. These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain
Pharmacogenomics Market Worth $13.16 billion by 2029
Meticulous Research®-a leading global market research company, published a research report titled, 'Pharmacogenomics Market by Technology (PCR, Sequencing, Spectrometry, Electrophoresis), Application (Cancer, Cardiology, Neurology, Infectious Diseases), End User (Hospitals, Diagnostic Laboratories, Research Institutes)-Global Forecast to 2029.' Download Free Research Sample @ https://www.meticulousresearch.com/download-sample-report/cp_id=5366 According to this latest publication from Meticulous Research®, the global pharmacogenomics market is projected to reach $13.16 billion by 2029, at a CAGR of 8.6% during the forecast period